Skip to main content

Find Clinical Trials

Home
Conditions
CD30-Positive Gray Zone Lymphoma

Clinical trial condition

CD30-Positive Gray Zone Lymphoma

Explore clinical trials studying CD30-Positive Gray Zone Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

CD30-Positive Gray Zone Lymphoma trial results

Completed

Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients

NCT01994850

Conditions: CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive Diffuse Large B-Cell Lymphoma, CD30-Positive Gray Zone Lymphoma
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details